Tempest Therapeutics, Inc. · NASDAQ:TPST
Tempest Therapeutics, Inc. shareholders
As of Jun 30, 2026, 19 institutions reported holding Tempest Therapeutics, Inc., 7.1% of its shares. Largest: Sabby Management, LLC, Vanguard and Geode Capital. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Tempest Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Sabby Management, LLC | 511K | 3.6% | +493K | Aug 14, 2026 |
| Vanguard | 303K | 2.1% | no change | Aug 13, 2026 |
| Geode Capital | 86,625 | 0.60% | −365 | Aug 12, 2026 |
| BlackRock | 39,068 | 0.27% | no change | Aug 7, 2026 |
| Squarepoint Ops LLC | 30,900 | 0.22% | new | Aug 14, 2026 |
| Northern Trust | 20,136 | 0.14% | +6,083 | Aug 13, 2026 |
| Citadel | 19,820 | 0.14% | new | Aug 14, 2026 |
| UBS | 5,636 | 0.04% | +1,103 | Aug 13, 2026 |
| Tower Research Capital LLC (TRC) | 3,922 | 0.03% | +1,132 | Aug 11, 2026 |
| Morgan Stanley | 2,022 | 0.01% | −36 | Aug 13, 2026 |